How Do Drugs Get Invented?

แชร์
ฝัง
  • เผยแพร่เมื่อ 9 มิ.ย. 2022
  • With support from the National Institute for Health Care Management, we’re spending the next three episodes talking about how drugs get approved in the United States. In this first episode, we discuss the drug approval process from the discovery phase all the way to what happens after its approval.
    Related HCT episodes:
    1. Ketamine as a Treatment for Depression?: • Ketamine as a Treatmen...
    Be sure to check out our podcast!
    • Podcast
    Other Healthcare Triage Links:
    1. Support the channel on Patreon: vid.io/xqXr
    2. Check out our Facebook page: goo.gl/LnOq5z
    3. We still have merchandise available at www.hctmerch.com
    4. Aaron's book "The Bad Food Bible: How and Why to Eat Sinfully" is available wherever books are sold, such as Amazon: amzn.to/2hGvhKw
    Credits:
    Aaron Carroll -- Writer
    Tiffany Doherty -- Writer, Social Media
    John Green -- Executive Producer
    Stan Muller -- Director, Producer
    Mark Olsen - Creative Director, Producer

ความคิดเห็น • 24

  • @aowens40601
    @aowens40601 2 ปีที่แล้ว +3

    This isn't about invention, its about approval. The title is misleading.

  • @DonaldAMisc
    @DonaldAMisc 2 ปีที่แล้ว +22

    Pharmaceuticals: "Can take up to 15 years for approval."
    Supplements: "Sucks to be you!"

    • @Jay-ho9io
      @Jay-ho9io 2 ปีที่แล้ว +3

      Except one has a much higher effectiveness rate than the other.
      Which is why the overwhelming majority of supplements make suckers out of people.

  • @aaroncobeng
    @aaroncobeng 2 ปีที่แล้ว +9

    Looks like a new attachment to my lecture in drug approvals. Thanks! I hope you also cover pharmacovigilance as well

  • @travis8674
    @travis8674 2 ปีที่แล้ว +8

    "If there are already treatments on the market with fewer side effects, the benefits of the drug really need to be better to outweigh additional risks."
    The onslaught of "me too" drugs with little to no benefit really makes me skeptical about this claim.

    • @pokepaar3696
      @pokepaar3696 2 ปีที่แล้ว +3

      I think he means that they should be "noninferior". It can work just as well, then there's just more options on the market

  • @mydailyreward2090
    @mydailyreward2090 ปีที่แล้ว

    At what point does the DEA assign a schedule to an addictive substance?

  • @SJR275
    @SJR275 2 ปีที่แล้ว +1

    Helloooooooo, my MSc was in Drug Discovery and Development. Very good topic and made me a little more sympathetic towards the actual investments that need to be made in the the drug industry and the general regulations of the ICH etc.
    Guessing a mention about the talks of fast track drug applications on the FDA to help reduce the upfront costs of drug development?
    There's a lot to go through in just 3 episodes, good luck!

  • @Amantducafe
    @Amantducafe 2 ปีที่แล้ว +11

    I'm conflicted into seeing this as a good thing or as a bad thing.
    On the positive side, we have scrutiny, safety and lots of regulations to make sure only 1 of 5,000 is approved.
    On the negative side, only big pharmaceutical companies would be able to afford putting out 5,000 researches only to have 1 approved and make a profit out of it meaning there is no way a lone researcher or the government would be able to pursue this without being affiliated or "selling their idea" to a pharmaceutical company.
    This kinda monopolizes the market of R&D of drugs

    • @CollinMaessen
      @CollinMaessen 2 ปีที่แล้ว +3

      Not really. Most drugs fail because they look like they might work in for example a cell culture, but wouldn't work in a human. And there's a lot that would prevent it like toxicity, no viable way to get it to the target location, practical issues like insane amounts, stability of the compound, only working temporarily, and the list goes on. And a lot of this already crops up before you even get to test it on a person.
      Trust me, I know. As I've seen a lot of promising compounds fail after cell culture testing for the illness that I have.

    • @Amantducafe
      @Amantducafe 2 ปีที่แล้ว

      @@CollinMaessen You completly missed my point.

    • @CollinMaessen
      @CollinMaessen 2 ปีที่แล้ว +2

      @@Amantducafe No I didn't. What I was not clear about is that this basic research is done mostly by medical researchers. Who aren't working for pharmaceutical companies. Those companies most of the time get involved after a promising compound/mechanism/technique is found to fund that.

    • @cbpd89
      @cbpd89 2 ปีที่แล้ว

      The vast majority of the research is funded by government grants. Pharma companies are too focused on profit to actually pay for their own research.

    • @CollinMaessen
      @CollinMaessen 2 ปีที่แล้ว

      @@cbpd89 Exactly. Makes medical research and developing treatments for rare illnesses/diseases loads of fun.

  • @ChiBStudio
    @ChiBStudio 2 ปีที่แล้ว +2

    Off topic a bit here: but what is the deal with this “cure for cancer” being popped up everywhere now? I know a cure hasn’t been officially found… that it’s a “hopeful cure”… but could you do a video for us non-medical people explaining fact from fiction that’s been traveling?

  • @AgentLokVokun
    @AgentLokVokun 2 ปีที่แล้ว

    6 minute video to say "Not in your garage" :thinking:

  • @DrMichaelCote
    @DrMichaelCote 2 ปีที่แล้ว

    🤔 I wonder if there's a way to fast track this process with the 1,000's of years of documented use of traditional medicines. Like mathematical proofs that can expedite the process and help more people.

  • @God-ld6ll
    @God-ld6ll 2 ปีที่แล้ว +4

    drugs

  • @km1dash6
    @km1dash6 2 ปีที่แล้ว +4

    One of the biggest problems is that about 90% of the funding goes to studying how chemical reactions happen in test tubes, or how isolated proteins react under controlled conditions. This was a problem with COVID, as a lot of the studies on disease didn't actually look at what disease does to the human body.

    • @aaroncobeng
      @aaroncobeng 2 ปีที่แล้ว +1

      Yes because you can't skip over that part. It would be wrong if we just tested immediately on humans if we don't have sufficient data if the candidate drug would have the possibility of efficacy or have the chance of high toxicity / lethality. We need screen these compounds first in vitro, then through animal models then we can move to human trials

  • @patlevv7382
    @patlevv7382 2 ปีที่แล้ว +1

    🆒‼️🌈